Fredun Pharmaceuticals Ltd - 539730 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
In compliance to Regulation 44(3) of SEBI Listing Regulations, 2015; we hereby submit the Voting Results of the of the business transacted at the 32nd Annual General Meeting (the '32nd AGM') of the Company for the Financial Year 2018-19 held on Tuesday, September 24, 2019 along with the Scrutinizer Report. Fredun Pharmaceuticals Ltd - 539730 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
In compliance to Regulation 44(3) of SEBI Listing Regulations, 2015; we hereby submit the Voting Results of the of the business transacted at the 32nd Annual General Meeting (the '32nd AGM') of the Company for the Financial Year 2018-19 held on Tuesday, September 24, 2019 along with the Scrutinizer Report. Fredun Pharmaceuticals Ltd - 539730 - Proceedings Of The 32Nd Annual General Meeting For The Financial Year 2018-19
In compliance to Regulation 30 read with Schedule III of SEBI Listing Regulations, 2015; we are pleased to submit the Proceedings of the 32nd Annual General Meeting of the Company. Fredun Pharmaceuticals Ltd - 539730 - Receipt Of Award From Saraswat Co-Operative Bank Ltd.
We are happy to share with our stakeholders that Mr. Fredun Medhora, Managing Director & CFO of the Company has received a Prestigious award from Saraswat Co-operative Bank Ltd. - 'Elite Customer Award' for the year 2018-19 at the Bank's Annual Staff day held on Thursday, September 19, 2019; recognising the efforts of Mr. Fredun Medhora taking the Company to the glorious heights; presented by Mr. Gautam Eknath Thakur, Chairman and Mr. Shashikant Keshav Sakhalkar, Vice-Chairman of the Saraswat Co-operative Bank Ltd. Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In reference to the 32nd Annual Report of the Company been dispatched to our Members and filled with the BSE and in compliance to Regulation 30 of the SEBI Listing Regulations, 2015; please find attached herewith the copies of newspaper advertisement published on Wednesday, September 18, 2019; in Business Standard and Mumbai Lakshadeep; informing the Members about the Corrigendum being issued in partial modification to the Notes on the Cash Flow Statement on Pg. No. 82 of the 32nd Annual Report. Fredun Pharmaceuticals Ltd - 539730 - Reg. 34 (1) Annual Report
In compliance to Regulation 34(1) of SEBI Listing Regulations, 2015; please find attached herewith the 32nd Annual Report of the Company for the Financial Year 2018-19. Fredun Pharmaceuticals Ltd - 539730 - Reg. 34 (1) Annual Report
In compliance to Regulation 34(1) of SEBI Listing Regulations, 2015; please find attached herewith the 32nd Annual Report of the Company for the Financial Year 2018-19. Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached herewith the copies of the newspaper advertisements published in Business Standard & Mumbai Lakshadeep newspaper on Saturday, August 31, 2019; informing the Members about the dispatch of the 32nd Annual General Meeting Notice and Annual Reports; remote E-voting information and Book Closure. Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Meeting Updates
Pursuant to Regulation 30 and other applicable provisions of SEBI Listing Regulations, 2015; we enclose herewith the Notice of the 32nd Annual General Meeting of the Company scheduled to be held on Tuesday, September 24, 2019 at 09:00 A.M. at Ramee Guest Line Hotel, Dadar Plot No. 3, Kohinoor Road, Dadar, Mumbai - 400 014 along with the Proxy form and Attendance slip. Fredun Pharmaceuticals Ltd - 539730 - Outcome Of The Conference Call Held On On August 26, 2019 At 5:00 P.M.
This is in reference to the Conference Call that was scheduled on August 26, 2019 at 5:00 P.M. Mr. Fredun Medhora, Managing Director of the Company addressed all these queries; as raised by the various Investors to their satisfaction. The Conference call started as scheduled at 5:00 P.M. and concluded at 6:12 P.M.